Microbot Medical (MBOT) closed at $0.64 on November 16, 2026, down 34.2% from the previous close, on volume of 9,474,494 shares (30-day average 891,014).
Data as of November 16, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 16, 2026 | Call Spread | 21-Jan-281 : 2.5 C | 300 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 16, 2026. See the largest for 5, 30, 60 and 90 days
Biggest stock movers Tuesday: Managed care stocks, ACM, RCAT, and more
Seeking Alpha News (Tue, 17-Nov 9:51 AM ET)
Biggest stock movers Tuesday: ACM, RCAT, and more
Seeking Alpha News (Tue, 17-Nov 5:16 AM ET)
Stem Inc Issues Regulation FD Disclosure on Financial Results
TipRanks (Mon, 16-Nov 5:10 PM ET)
Stem Appoints Jessica Palomino as Chief Legal Officer
TipRanks (Mon, 16-Nov 5:06 PM ET)
Stem shares sink 18% after-hours post $10M Athena IP sale to Voltus
Seeking Alpha News (Mon, 16-Nov 4:40 PM ET)
Stem GAAP EPS of -$1.51 beats by $0.03, revenue of $36.66M misses by $2.5M
Seeking Alpha News (Mon, 16-Nov 4:10 PM ET)
Here are the major earnings after the close Monday
Seeking Alpha News (Mon, 16-Nov 10:00 AM ET)
Microbot Medical Reports Third-Quarter Results and Commercial Progress
TipRanks (Mon, 16-Nov 9:08 AM ET)
Microbot Medical reports Q3 results
Seeking Alpha News (Mon, 16-Nov 8:54 AM ET)
Microbot Medical Files 10-Q and Highlights Key Third Quarter Operating Achievements
Globe Newswire (Mon, 16-Nov 8:30 AM ET)
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
Microbot Medical trades on the NASDAQ stock market under the symbol MBOT.
As of November 17, 2026, MBOT stock price climbed to $0.69 with 972,483 million shares trading.
MBOT has a beta of 1.09, meaning it tends to be more sensitive to market movements. MBOT has a correlation of 0.04 to the broad based SPY ETF.
MBOT has a market cap of $46.34 million. This is considered a Sub-Micro Cap stock.
Last quarter Microbot Medical reported $72,000 in Revenue and -$.09 earnings per share. This fell short of revenue expectation by $-298,000 and missed earnings estimates by -$.01.
In the last 3 years, MBOT traded as high as $4.67 and as low as $.52.
The top ETF exchange traded funds that MBOT belongs to (by Net Assets): VTI, VXF, IWC, QQQS.
MBOT has underperformed the market in the last year with a price return of -66.7% while the SPY ETF gained +10.3%. MBOT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -55.5% and -33.7%, respectively, while the SPY returned -5.3% and -2.5%, respectively.
MBOT support price is $.61 and resistance is $.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MBOT shares will trade within this expected range on the day.